<DOC>
	<DOCNO>NCT01674803</DOCNO>
	<brief_summary>The introduction drug-eluting stent ( DES ) treatment coronary artery disease lead significant reduction morbidity . However , first generation device positive impact mortality PCI ( compare bare metal stent ) , greatly attribute somewhat increased incidence late late stent thrombosis . Concerns role durable polymer potential trigger inflammation finally adverse event also lead development DES biodegradable coating , leave degradation coating bare metal stent vessel wall induce inflammatory response . While biodegradable polymer DES increasingly use clinical practice , data available head-to-head comparison biodegradable contemporary third generation durable polymer DES .</brief_summary>
	<brief_title>Comparison BIOdegradable Polymer DuRablE Polymer Drug-eluting Stents All COmeRs PopulaTion ( BIO-RESORT )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<criteria>Minimum age 18 year . Significant coronary artery disease lesion ( ) eligible treatment drug elute stent accord clinical guideline and/or operator ' judgement . Capable provide informed consent . Patients clinical syndrome enrol without exclusion base number , type , location , length lesion treat . Known intolerance component one stent investigate known intolerance antithrombotic and/or anticoagulant therapy prevents adherence dual antiplatelet therapy . Planned elective surgical procedure necessitate interruption dual antiplatelet therapy first 6 month randomization . Participation another randomize drug device trial reach primary endpoint . Adherence schedule followup unlikely life expectancy assume less 1 year . Known pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>drug-eluting stent</keyword>
	<keyword>zotarolimus</keyword>
	<keyword>everolimus</keyword>
	<keyword>sirolimus</keyword>
	<keyword>comer population</keyword>
	<keyword>target vessel failure</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>durable polymer</keyword>
	<keyword>biodegradable polymer</keyword>
</DOC>